Drug Discovery and Screening
We support preclinical therapeutic development using advanced human-relevant disease models and multi-layered molecular analyses.
Drug Discovery & Development
Key Applications
Nocteva's human cell and organoid platforms deliver physiologically relevant systems for evaluating drug candidates across the entire discovery and development pipeline. By pairing disease-relevant models with advanced molecular and functional readouts, we enable more predictive assessment of efficacy, safety, and mechanism of action — reducing risk well before clinical translation.
Efficacy Testing
Evaluate therapeutic candidates in disease-relevant cellular and organoid models to determine their ability to modify disease-associated phenotypes.
Safety Assessment
Identify potential toxicity and off-target effects using advanced human tissue models and functional assays.
Mechanism of Action Studies
Investigate how therapeutic interventions affect molecular pathways, cellular behavior, and tissue function.
Lead Candidate Prioritization
Compare and rank candidate compounds based on efficacy, safety, and biological activity to support data-driven decision making.
